Phase 1 Study of OTS167 in Patients With Solid Tumors
NCT01910545
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Metastatic Tumors
Interventions
DRUG:
OTS167IV
Sponsor
OncoTherapy Science, Inc.